# The Safety and Efficacy of 'AVI' Stent for Treating Coronary Revascularization

> **NCT02117843** · NA · UNKNOWN · sponsor: **Beijing AmsinoMed Medical Device Co., Ltd** · enrollment: 1200 (estimated)

## Conditions studied

- Ischemic Heart Disease
- Myocardial Ischemia
- Coronary Disease
- Acute Coronary Syndrome

## Interventions

- **DEVICE:** AVI® Arsenic trioxide drug eluting stent

## Key facts

- **NCT ID:** NCT02117843
- **Lead sponsor:** Beijing AmsinoMed Medical Device Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-07
- **Primary completion:** 2017-12
- **Final completion:** 2021-04
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2017-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02117843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02117843, "The Safety and Efficacy of 'AVI' Stent for Treating Coronary Revascularization". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02117843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*